Clinical Study of Platelet-rich Plasma Promoting Tendon-bone Healing in Anterior Cruciate Ligament Reconstruction

December 2, 2020 updated by: Beijing Tsinghua Chang Gung Hospital

Anterior cruciate ligament (ACL) injury is a common knee injury, which seriously affects the living ability and sport level of the injured. ACL reconstruction is the main method to treat ACL injury. Due to the reconstructive ligament needs a tendon bone healing and ligament maturation, therefore, in the ACL anatomical study, reconstruction surgery and reconstruction materials under the condition of constant progress, how to improve the ACL reconstruction of tendon bone healing and shorten the time of the ligament mature, improve the clinical effect of ACL reconstruction, has become the focus in the ACL reconstruction.

Autologous platelet-rich plasma (PRP) is full of growth factors and bioactive factors, which has the function of promoting tissue healing, anti-inflammatory and analgesic effects. At the same time of anterior cruciate ligament reconstruction, using autologous PRP in the bone channel might promote tendon bone healing and ligament maturing after ACL reconstruction, promote the recovery of proprioception, prevent bone channel expanding, shorten the postoperative recovery time, speed up the patients recovery exercise ability, improve the clinical effect of ACL reconstruction.

In this study, patients with ACL injuries were randomly divided into two groups: one group underwent ACL anatomical reconstruction, and the other group underwent ACL anatomical reconstruction with PRP. Various clinical scores, KT-2000, Biodex and imaging tests were used to evaluate the differences in the clinical effects of the two surgical methods in terms of postoperative pain, joint swelling, knee function, joint stability, muscle strength recovery, bone channel expanding, ligament vasinization, and ligament maturation.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 50 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • History of knee injury
  • History of knee instability
  • Anterior drawer test (+), or / and Lachman test (+)
  • The tear of anterior cruciate ligament was confirmed by MRI

Exclusion Criteria:

  • The injury of other ligaments of knee joint, such as complex posterior cruciate ligament injury, lateral collateral ligament injury and medial collateral ligament injury above III degree
  • Patients with meniscus removed
  • Patients with moderate to severe articular cartilage injury
  • Patients with complex nerves and blood vessels injury
  • Patients with compound intra - and periarticular fractures of the knee
  • Patients with intra or periarticular fractures of the knee
  • Patients with contralateral knee instability
  • Patients with severe cardiovascular and cerebrovascular diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Platelet-Rich Plasma
Four semitendinosus tendons and gracilis tendons are prepared. 4 ml platelet-rich plasma is completely absorbed by a gelatin sponge and fixed in the center of the four tendons. 4-0 absorbable line is used for fixation.Then we use conventional surgical techniques to reconstruct the ACL.
36 ml of peripheral blood is extracted from patients, and 4 ml of 3.8% sodium citrate is added for anticoagulation. After centrifugation for 2 times, 4 ml platelet-rich plasma will be prepared.Four semitendinosus tendons and gracilis tendons are prepared.
NO_INTERVENTION: control group
We performed conventional surgical techniques to reconstruction without using platelet-rich plasma.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tendon bone healing and ligament maturing
Time Frame: CT and MRI were performed on the fourth day after operation

The diameter of bone canal was evaluated by CT, it is measured in millimeters (mm).

The tendon bone healing and ligament maturing was evaluated by MRI. According to the same level of anterior cruciate ligament, femoral canal, posterior cruciate ligament, background noise, with the diameter of 3.3 mm as the center, the lowest signal value point was measured, and the final point was compared to obtain the Signal-Noise Ratio.

CT and MRI were performed on the fourth day after operation
tendon bone healing and ligament maturing
Time Frame: CT and MRI were performed on one year after operation

The diameter of bone canal was evaluated by CT, it is measured in millimeters (mm).

The tendon bone healing and ligament maturing was evaluated by MRI. According to the same level of anterior cruciate ligament, femoral canal, posterior cruciate ligament, background noise, with the diameter of 3.3 mm as the center, the lowest signal value point was measured, and the final point was compared to obtain the Signal-Noise Ratio.

CT and MRI were performed on one year after operation
proprioception and Knee joint function
Time Frame: 3 months after the operation

KT-2000, it was used to assess the stability of the tibia and the results were expressed in millimeters.

Biodex, it is used to assess the strength and function of joints. The contralateral knee joint was taken as the reference. The percentage of strength between the affected knee joint and the contralateral knee joint was obtained

3 months after the operation
proprioception and Knee joint function
Time Frame: 6 months after the operation

KT-2000, it was used to assess the stability of the tibia and the results were expressed in millimeters.

Biodex, it is used to assess the strength and function of joints. The contralateral knee joint was taken as the reference. The percentage of strength between the affected knee joint and the contralateral knee joint was obtained

6 months after the operation
proprioception and Knee joint function
Time Frame: 1 year after the operation

KT-2000, it was used to assess the stability of the tibia and the results were expressed in millimeters.

Biodex, it is used to assess the strength and function of joints. The contralateral knee joint was taken as the reference. The percentage of strength between the affected knee joint and the contralateral knee joint was obtained

1 year after the operation
Knee pain
Time Frame: 3 months after the operation
Visual Analog Score for pain, it is used to assess the patient's pain, the full score is 10.
3 months after the operation
Knee pain
Time Frame: 6 months after the operation
Visual Analog Score for pain, it is used to assess the patient's pain, the full score is 10.
6 months after the operation
Knee pain
Time Frame: 1 year after the operation
Visual Analog Score for pain, it is used to assess the patient's pain, the full score is 10.
1 year after the operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2016

Primary Completion (ANTICIPATED)

November 9, 2021

Study Completion (ANTICIPATED)

November 9, 2021

Study Registration Dates

First Submitted

November 23, 2020

First Submitted That Met QC Criteria

December 2, 2020

First Posted (ACTUAL)

December 9, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 9, 2020

Last Update Submitted That Met QC Criteria

December 2, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 12017B3003

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Injury

Clinical Trials on Platelet-Rich Plasma

3
Subscribe